Where is the live CopyMark page for USPTO serial 76340242?

The live record is at https://getcopymark.com/trademark/76340242. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns XANODYNE PHARMACAL?

According to the public USPTO record for serial number 76340242, the listed owner(s) include: SILVER POINT FINANCE, LLC, SILVER POINT FINANCE, LLC, XANODYNE PHARMACAL, INC..

What is USPTO serial number 76340242?

Serial number 76340242 is the USPTO application identifier for the mark XANODYNE PHARMACAL. It is used to track examination, publication, and registration of this trademark.

What is the current status of XANODYNE PHARMACAL?

XANODYNE PHARMACAL (76340242) currently shows USPTO status code 606 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover XANODYNE PHARMACAL?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: XANODYNE PHARMACAL Serial# 76340242 | status 606; last event ASCK | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XANODYNE PHARMACAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

SILVER POINT FINANCE, LLC
GREENWICH, CT
Other trademarks owned by SILVER POINT FINANCE, LLC
SILVER POINT FINANCE, LLC
GREENWICH, CT
Other trademarks owned by SILVER POINT FINANCE, LLC
XANODYNE PHARMACAL, INC.
Florence, KY
Other trademarks owned by XANODYNE PHARMACAL, INC.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kurt A. Summe

KURT A SUMME WOOD, HERRON & EVANS, LLP2700 CAREW TWR441 VINE STCINCINNATI, OH 45202

Goods and services

Class	Description	Status	First use
005	line of pharmaceuticals for consumption and use by humans, namely, oncology, hematology, pain management and stimulant pharmaceuticals and compositions	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Oct 26, 2011	ASCK	ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY	—
Dec 27, 2006	MAB6	ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 27, 2006	ABN6	ABANDONMENT - NO USE STATEMENT FILED	The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 25, 2006	NOAM	NOA MAILED - SOU REQUIRED FROM APPLICANT	A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 31, 2006	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 11, 2006	NPUB	NOTICE OF PUBLICATION	—
Dec 19, 2005	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Dec 16, 2005	ALIE	ASSIGNED TO LIE	—
Dec 14, 2005	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Dec 2, 2005	RCCK	SUSPENSION CHECKED - TO ATTORNEY FOR ACTION	—
Jun 1, 2005	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Nov 24, 2004	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Nov 10, 2003	CNSL	LETTER OF SUSPENSION MAILED	—
Sep 23, 2003	CFIT	CASE FILE IN TICRS	—
Sep 8, 2003	PETG	PETITION TO REVIVE-GRANTED	—
Jul 14, 2003	PETR	PETITION TO REVIVE-RECEIVED	—
Jul 14, 2003	MAIL	PAPER RECEIVED	—
May 13, 2003	ABN2	ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE	The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 27, 2002	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 12, 2002	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Aug 12, 2002	MAIL	PAPER RECEIVED	—
Aug 6, 2002	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Feb 6, 2002	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2002	DOCK	ASSIGNED TO EXAMINER	—

XANODYNE PHARMACAL